ClinicalTrials.Veeva

Menu

Assessment of Thyroid Doppler Ultrasound in Followup of Pediatric Graves' Disease

A

Assiut University

Status

Not yet enrolling

Conditions

Graves' Disease

Study type

Observational

Funder types

Other

Identifiers

NCT06357494
Thyroid Doppler in Graves'

Details and patient eligibility

About

All cases of the study will be diagnosed as Graves' by History, examination, laboratory (FT3, FT4, TSH & TRAbs), X-ray on left wrist for bone age, neck grey scale ultrasonography for thyroid gland size, shape, echotexture, vascularity and nodule characters if present with TIRAD score calculation.

Then Color flow doppler ultrasound will be done to asses thyroid volume, number of vessels per square cm and inferior thyroid artery peak systolic velocity, end diastolic velocity and resistive index. Patients then will receive carbimazole antithyroid drug at dose 0.25-0.5 mg/kg/day PO & the dose will be titrated according to thyroid function test after 4-6 weeks.

Beta-adrenergic blockade will be added to all symptomatic cases. Regular follow up will be done every month of first 3 months of diagnosis and then every 3 months for 2 years by clinical and thyroid function test to asses response, compliance, complications, drug side effects, remission and relapses.

Doppler ultrasound will be done at 0, 12 and 24 months.

Enrollment

32 estimated patients

Sex

All

Ages

1 to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All newly diagnosed children with clinical and laboratory hyperthyroidism (high T4 & low TSH) with positive TRAbs.

Exclusion criteria

  • Patients receiving radioiodine Patients underwent thyroid surgery History of neck radiation or neck surgery

Trial contacts and locations

0

Loading...

Central trial contact

Hanaa A Mohamad, Professor of pediatrics

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems